Differential Diagnosis of Jaundice in Adults
Primary Classification Framework
The first critical step is to determine whether hyperbilirubinemia is conjugated (direct) or unconjugated (indirect), as this fundamentally divides the differential diagnosis into distinct pathophysiologic categories. 1, 2
Unconjugated (Indirect) Hyperbilirubinemia
Hemolytic Causes
- Hemolysis accounts for 2.5% of jaundice cases in U.S. studies and produces unconjugated hyperbilirubinemia through bilirubin overproduction. 1
- Coombs-negative hemolytic anemia occurs in 10-25% of chronic liver disease patients presenting with jaundice. 2
Impaired Conjugation
- Gilbert syndrome represents 5.6% of jaundice cases and is the most common inherited cause of unconjugated hyperbilirubinemia. 2
- Crigler-Najjar syndrome creates constitutional predisposition to unconjugated hyperbilirubinemia. 2
Conjugated (Direct) Hyperbilirubinemia
Hepatocellular Causes
Sepsis/shock is the most common etiology in U.S. studies, accounting for 22-27% of severe jaundice cases, creating mixed unconjugated and conjugated hyperbilirubinemia through both hemolysis and hepatic dysfunction. 2
- Decompensation of pre-existing cirrhosis is the second most common cause of new-onset jaundice at 20.5%, representing the primary mechanism in established chronic liver disease patients. 2
- Alcoholic liver disease accounts for 16% of jaundice cases, with alcoholic hepatitis commonly presenting as the first manifestation of decompensated disease. 1, 2
- Drug-induced liver injury represents 0.5-7% of cases and constitutes one of the four most common causes of jaundice in the United States. 2
- Viral hepatitis accounts for only 0.2% of severe jaundice cases but remains an important consideration. 2
- Autoimmune hepatitis accounts for 0.2% of severe jaundice cases. 2
Cholestatic/Obstructive Causes
Malignancy accounts for 6.2% of U.S. jaundice cases but represents the most common etiology of severe jaundice in European populations. 1, 2
- Choledocholithiasis represents 13-14% of jaundice cases, with multiple small gallstones (<5 mm) creating 4-fold increased risk for common bile duct migration. 2
- Pancreatic disorders, such as pancreatitis and pancreatic malignancy, can cause biliary obstruction and jaundice. 1
- Cholangiocarcinoma and other bile duct disorders can cause jaundice. 1
Infiltrative Causes (with Hepatosplenomegaly)
When jaundice presents with both hepatomegaly and splenomegaly, strongly favor an intra-hepatic cause rather than simple extra-hepatic biliary obstruction. 2
- Hematologic malignancies (lymphoma, leukemia, multiple myeloma) may diffusely infiltrate the liver, producing cholestasis together with hepatosplenomegaly. 2
- Metastatic carcinoma to the liver creates an infiltrative intra-hepatic cholestatic pattern. 2
- Hepatic sarcoidosis leads to granulomatous infiltration, resulting in cholestasis and hepatosplenomegaly. 2
- Systemic amyloidosis may involve both liver and spleen, producing a cholestatic biochemical profile. 2
Vascular Causes
- Budd-Chiari syndrome (hepatic vein thrombosis) produces hepatomegaly, splenomegaly, and cholestatic jaundice. 2
- Hepatic veno-occlusive disease yields a similar constellation of findings. 2
- Congestive hepatopathy secondary to right-sided heart failure causes hepatic congestion with cholestasis and can progress to cardiac cirrhosis with splenomegaly. 2
Advanced Primary Biliary Disorders
- Advanced primary biliary cholangitis (PBC) frequently develops portal hypertension with accompanying splenomegaly. 2
- Primary sclerosing cholangitis (PSC) commonly progresses to cirrhosis; hepatomegaly and splenomegaly are the most frequent findings at diagnosis. 2
- IgG4-associated cholangitis can clinically mimic PSC. 2
Initial Diagnostic Approach
Laboratory Evaluation
Initial investigation should include bilirubin (total and fractionated), albumin, ALT, ALP, and GGT, together with a full blood count. 3
- Measuring fractionated bilirubin allows determination of whether the hyperbilirubinemia is conjugated or unconjugated. 4
- An AST:ALT ratio >1 indicates advanced fibrosis/cirrhosis. 3
- Elevated alkaline phosphatase and GGT indicate the presence of cholestasis. 5
Extended Aetiology Panel (when indicated)
- Viral hepatitis: Hepatitis B surface antigen AND hepatitis C antibody (with follow-on PCR if positive). 3
- Iron overload: Ferritin AND transferrin saturation. 3
- Autoimmune liver disease: Anti-mitochondrial antibody, anti-smooth muscle antibody, antinuclear antibody, serum immunoglobulins. 3
- Metabolic liver disease: Alpha-1-antitrypsin level; thyroid function tests; caeruloplasmin (age >3 and <40 years). 3
Imaging
Abdominal ultrasonography should be performed immediately to rule out dilated bile ducts, detect mass lesions, and assess liver texture and spleen size. 2
- Ultrasound sensitivity ranges from 65-95% for detecting cirrhosis and 32-100% for identifying biliary obstruction. 2
- If ultrasound does not reveal ductal dilatation but clinical suspicion persists, magnetic resonance cholangiopancreatography (MRCP) should be considered. 2
Histologic Evaluation
- Liver biopsy is indicated when non-invasive studies are inconclusive; a specimen should contain at least ten portal tracts for adequate assessment. 2
Critical Clinical Pitfalls
- Alarm symptoms that require urgent evaluation include abdominal pain, fever, and chills, which suggest cholangitis or cholecystitis. 5
- Drug-induced cholestasis should be evaluated by reviewing medication exposure within the prior six weeks. 2
- When diagnosis remains uncertain, measurement of serum IgG4 levels is recommended to exclude IgG4-related cholangitis. 2
- Prompt ultrasonography is emphasized; delaying imaging while awaiting extensive laboratory results can postpone critical diagnosis. 2
budget:budget_used